Phase I/II, two-part, open-label, multiple-dose, dose-escalation study of siltuximab in patients with solid tumors

Author(s):
Angevin, E.; Elez, E.; Cohen, S.J.; Laethem, J.L. van; Ottensmeier, C.; Joly, F.; Ray-Coquard, I.; Lopez-Martin, J.A.; Dirix, L.; Machiels, J.P.; Clive, S.; Steven, N.M.; Reddy, M.; Hall, B.; Puchalski, T.; Bandekar, R.; Velde, H. van de; Tromp, B.J.; Vermeulen, J.; Kurzrock, R.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-05-20
Language
English
Is part of
Journal of Clinical Oncology (2012), No. 15
hdl
1887/105439